# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Dan Brennan maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $648 ...
Raymond James analyst Andrew Cooper maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price tar...
RBC Capital analyst Conor McNamara maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price targ...
Stifel analyst Daniel Arias maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $600 t...
Baird analyst Catherine Schulte maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price target ...
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in ov...
Thermo Fisher Scientific's Q2 revenue of $10.54 billion surpassed expectations, with segments showing mixed results. Adjust...